Document text
Principal Investigator: James M Dubois
Organization: WASHINGTON UNIVERSITY
Fiscal Year: 2024
Award: $458,341
Funding agency: National Human Genome Research Institute
Religion is a primary driver of concerns with genomics and genomic healthcare (GGH). It is vital for research on the ethical, legal, and social implications (ELSI) of genomics to understand the role of religion in shaping public attitudes toward GGH. Ninety percent of the US public believes in some kind of higher power and 55% pray daily. The US public attends religious services at a rate 3 times higher than scientists in the US, who are at risk of misunderstanding the role religion plays in attitudes toward GGH. Further, Black, Hispanic, and rural populations attend religious services more frequently than the general US public. Concerns with GGH activities may lead to lower levels of engagement of GGH, which may in turn contribute to health disparities. This project aims to understand why higher levels of religious practice are associated with greater concerns with GGH activities.
Additionally, this project will interview faith leaders to identify how public health genomics might engage faith communities in ways that are respectful and constructive. While some concerns with healthcare technologies may disappear with new information, others stem from worldviews, deep moral commitments, or mistrust of the healthcare system. Engaging religious communities is essential to identify which concerns can be addressed with information, which call for alternative responses, and what alternative responses might look like. Very few models exist for genomic public health engagement with religion, particularly models that directly address value-laden concerns.13,14
Terms: <2019-nCoV vaccine><21+ years old><Address><Adoption><Adult><Adult Human><Attitude><Belief><Bible><Black><Black Populations><Black group><Black individual><Black people><Black race><Blacks><COVID-19 vaccine><Cessation of life><Characteristics><Christianity><Communities><Data><Death><ELSI><Education><Educational Achievement><Educational Status><Educational aspects><Ensure><Faith><Faith leader><Frequencies><Genes><Genetic><Genomics><Health Care Activity><Health Care Systems><Health Care Technology><Health Technology><Healthcare><Healthcare Activity><Healthcare Systems><Healthcare Technology><Hispanic Populations><Hispanic group><Hispanic individual><Hispanic people><Hispanics><Human><Interview><Investigators><Islam><Jewish><Judaism><Knowledge><Learning><Life><Measurement><Messenger RNA><Modeling><Modern Man><Mohammedanism><Morals><Muslim><Muslim population group><Muslim religion><NHGRI><National Center for Human Genome Research><National Human Genome Research Institute><Participant><Persons><Play><Population><Prayers><Protestant><Public Health><Qualitative Research><RNA vaccine><RNA-based vaccine><Regression Analyses><Regression Analysis><Regression Diagnostics><Religion><Research><Research Methodology><Research Methods><Research Personnel><Researchers><Risk><Role><Rural Population><Rural group><Rural people><SARS-CoV-2 vaccine><SARS-coronavirus-2 vaccine><Sample Size><Sampling><Scientist><Services><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe acute respiratory syndrome coronavirus 2 vaccine><Shapes><Statistical Regression><Subgroup><Survey Instrument><Surveys><Technology><adulthood><coronavirus disease 2019 vaccine><coronavirus disease-19 vaccine><disparity in health><educational level><ethical legal and social><ethical, legal, and social implication><experience><follower of religion Jewish><gene testing><gene-based testing><genetic testing><health care><health disparity><innovate><innovation><innovative><instrument><interest><mRNA><mRNA vaccine><mRNA-based vaccine><moral><nCoV vaccine><nCoV-19 vaccine><nCoV19 vaccine><new technology><novel technologies><prenatal><progenitor cell based therapy><progenitor cell therapy><progenitor cell treatment><progenitor therapy><progenitor treatment><religious><religious group><research and methods><response><rural individual><social role><stakeholder insights><stakeholder perspectives><stem><stem and progenitor cell therapy><stem cell based therapy><stem cell mediated therapy><stem cell therapeutics><stem cell therapy><stem cell treatment><stem cell-based therapeutic><stem cell-based treatment><training achievement><training level><training status><unborn><vaccine against 2019-nCov><vaccine against COVID-19><vaccine against SARS-CoV-2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine candidates against SARS-CoV-2><vaccine for novel coronavirus><vaccines preventing COVID><vaccines to prevent COVID>